Notably, we did not notice a correlation of NPTX2 expression and clinical-pathological parameters, whereas van Roemeling et al. suggested an increase of NPTX2 in more advanced ccRCC [20]. This evidence concerns the gene NPTX2 and nonpapillary renal cell carcinoma.